Cell-Free DNA for the Management of Classical Hodgkin Lymphoma

Cell-free DNA (cfDNA) testing, is an emerging “liquid biopsy” tool for noninvasive lymphoma detection, and an increased amount of data are now available to use this technique with accuracy, especially in classical Hodgkin lymphoma (cHL). The advantages of cfDNA include simplicity of repeated blood s...

Descripción completa

Detalles Bibliográficos
Autores principales: Camus, Vincent, Jardin, Fabrice
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998645/
https://www.ncbi.nlm.nih.gov/pubmed/33801462
http://dx.doi.org/10.3390/ph14030207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7998645/
https://www.ncbi.nlm.nih.gov/pubmed/33801462
http://dx.doi.org/10.3390/ph14030207

Ejemplares similares